The C-Suite for Northwest Biotherapeutics (NWBO) is led by Linda F. Powers, who serves as Chairman, President, CEO, and CFO, with key scientific leadership from Dr. Alton L. Boynton as Chief Scientific Officer, alongside Marnix L. Bosch as Chief Technical Officer, all driving their mission in personalized cancer vaccines.
Key Executives:
Linda F. Powers: Chairman, President, CEO, and Chief Financial Officer (CFO).
Dr. Alton L. Boynton: Chief Scientific Officer (CSO) and Secretary.
Marnix L. Bosch: Chief Technical Officer (CTO).
This leadership team guides Northwest Biotherapeutics in developing its personalized immune therapies for solid tumors, known as DCVax®
Bullish
Market Data 
Markets 
AI
